This study is testing the safety of a new treatment called TCR1188-ABC cells for certain cancers with a KRAS mutation, which is a change in the DNA of cancer cells. It includes cancers like pancreatic, colorectal, cholangiocarcinoma, and non-small cell lung cancer. This study will help find out how much of the treatment can be given safely and if it works on these cancers.

**Key Points to Consider:**

• **Study Length & Visits:** The study involves multiple visits for treatment and monitoring.
• **Eligibility:** Only adults with specific cancer types and genetic changes can join.
• **Risks:** Possible side effects and risks will be explained by the study doctors.

To join, patients must have already tried some standard treatments for their cancer. They also need to be in good health overall, with working organs and no serious infections or other cancers. People with certain health issues like heart problems or active infections cannot join. Participants must agree to use birth control if they can have children.